6533b86dfe1ef96bd12c9ddf

RESEARCH PRODUCT

Irbesartan results in more complete blockade of human renal at1-receptor mediated effects than does candesartan cilexetil as evidenced by higher plasma renin levels

T. RoenzC. MangG. G. BelzE. MutschlerS. KoberR. ButzerP. LangguthC. Hausdorf

subject

KidneyAngiotensin II receptor type 1business.industryPharmacologyAngiotensin IIPlasma renin activityCandesartanmedicine.anatomical_structureLosartanIrbesartanRenin–angiotensin systemInternal Medicinemedicinebusinessmedicine.drughttps://doi.org/10.1016/s0895-7061(00)00639-7